A submitted manuscript is received with the understanding that it is an original contribution not previously published (except as an abstract or preliminary report), that it is not under consideration for publication elsewhere, and that, if accepted, it will not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors or the publisher.
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Unless written consent is obtained and submitted with the manuscript, eyes should be masked and names should be removed from figures.
Copyright: A copy of the Journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form must be signed by all authors and submitted with the manuscript to:
Philip E. LeBoit, MD
Dermatopathology Section
University of California
San Francisco, 1701 Divisadero Street
Room 350
San Francisco, CA 94115.
Permissions: Direct quotations, tables, or illustrations that have appeared in copyrighted material must be accompanied by written permission for their use from the copyright owner (usually the publisher) and the original author, along with complete information as to the source.
Preparation of Manuscript The American Journal of Dermatopathology conducts blinded peer reviews. Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
General format: Manuscripts should be submitted in English in triplicate (one original and two copies) and printed on standard 8?x 11-inch (21 x 28-cm) paper with at least a 1-inch (2.5 cm) margin on all sides. All copy including legends, footnotes, tables, and references should be double-spaced and printed on one side of the sheet only. Materials prepared on a word processor computer should be printed with a letter-quality printer. On acceptance for publication, a disk containing the final accepted version of the manuscript will be requested.
A disk should not be submitted until a manuscript has been accepted for publication. Title page: The title page on the original manuscript should contain (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment. The two copies should be identified with the article title only-do not include the author's name.
An Unstructured abstract or one sentence introduction and key words must accompany all submissions: Limit the abstract to 250 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (eg, "the significance of the results is discussed"). List three to five key words or phrases.
Text: The manuscript should be divided into four main headings: Introduction, Materials and Methods, Results, and Discussion. Abbreviations must be defined at first mention in text and in each table and figure. If a brand name is cited, manufacturer and address (city and state/country) should be supplied. All forms of support, including pharmaceutical industry support, must be acknowledged in the Acknowledgment section.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. The full term for which an abbreviation stands should precede its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. References should be typed (double-spaced) at the end of the manuscript. They should be cited in the text in the order of appearance. Unpublished data (papers submitted but not yet accepted for publication, personal communications) should be cited parenthetically in text. If there are more than three authors, references should contain the names of the first three authors and be followed by et al. For abbreviations of journal names, refer to List of Journals Indexed in
Index Medicus. This can be accessed at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Journal article
1. McKee PH, Fletcher CDM, Rasbridge SA. The enigmatic eccrine epithelioma. Am J Dermatopathol 1990;12:552-61.
Book chapter
2. Clonje E, Wilson-Jones E. Vascular tumors. In: Elder D, ed. Lever's histopathology of the skin. 8
th ed. Philadelphia: Lippincott, 1997: 889-932.
Entire book
3. Elder D, Elenitsas R. Lever's histopathology of the skin. Philadelphia: Lippincott, 1997.
Software
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.
Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
Figures: Figures must be cited consecutively in the text and numbered in the order in which they are discussed. All artwork should be submitted in triplicate in camera-ready form; illustrations should be glossy prints or high-quality, laser-printed illustrations. Include the last name of the senior author on the original set of figures only.
The two accompanying sets of figures should be identified with the article title only -- do not include the author's name. On the back of each figure, lightly write the figure number and figure part (1A, 1B, 1C), and an arrow to indicate the top edge of the figure on the back of each figure. Photocopies are unacceptable. Lettering should be large enough that it will remain legible after figure reduction; typewritten or unprofessional lettering is unacceptable. Figure parts (A, B, C) may be left unlabeled (but clearly marked on back) for professional placement by the Journal's printer.
Figure legends: Legends should be brief and specific, and they should appear after the references.
Do not indicate the magnification for light photomicrographs unless there are specific instances where visual inspection is inadequate for judging relative or absolute size. Use of scale markers in the image is suggested for electron micrographs, and the type of stain used should be indicated.
Color figures: The journal accepts for publication color figures that will enhance the article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Digital figures: Electronic art may be submitted as TIFF (Tagged Image File Format) or EPS (Encapsulated PostScript) files and must be accompanied by a high-quality print. Please include information on any digital manipulation of the figure (eg, "Image was altered using Adobe PhotoShop to enhance contrast and reduce background.") Preferred formats are PhotoShop and Illustrator. Each figure must be contained in an individual file on a high-density floppy disk, Iomega Zip, CD-R, or e-mail attachment. Always indicate the software used to create the art (eg, PhotoShop 5.0, Illustrator 7.0).
PowerPoint, Corel Draw, and files downloaded from the Internet cannot be used. Tables: Cite tables should consecutively in the text and number them in that order. Key each on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9
th edition). Stedman's Medical Dictionary (27
th edition) and Merriam Webster's Collegiate Dictionary (10
th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate the name. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
Address for manuscript submission: Send the manuscript with a cover letter that includes the corresponding author's e-mail address and full mailing address to Philip E. LeBoit, MD, Dermatopathology Section, University of California, San Francisco, 1701 Divisadero Street, Room 350, San Francisco, CA 94115; Phone: (415) 353-7550; Fax: (415) 353-7553; E-mail: dbaughm@itsa.ucsf.edu (please see the checklist at the end of these Instructions before mailing manuscripts). The editorial office will acknowledge receipt of your manuscript and will give you a manuscript number for your reference. Address all inquiries regarding manuscripts not yet accepted or published to the journal's editorial office.
After Acceptance
Disk submission: Lippincott Williams & Wilkins requires that authors submit an electronic version of the final accepted manuscript along with a printout of the final accepted manuscript. Electronic files should be submitted in a standard word processing format; Microsoft Word (or Corel WordPerfect) is preferred. Although conversions can be made from other word processing formats, the vagaries of the conversion process may introduce errors. Do not submit ASCII text files. Do not use automatic numbering or footnotes for references. The Journal does not assume responsibility for errors in the conversion of customized software, newly released software, and special characters. Authors preparing manuscripts on Macintosh computers should not use the Fast Save option. Each submitted disk must be clearly labeled with the name of the author, item title, journal title, word processing program and version, and file name used. The disk should contain only one file-the final version of the accepted manuscript.
Page proofs and corrections: Corresponding authors will receive page proofs to check the copyedited and typeset article before publication. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to make the article conform to Journal style should be allowed to stand if they do not alter the authors' meaning. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and returned within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form with the electronic page proofs that includes reprint costs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106 with any questions.
Publisher's contact: Fax corrected page proofs, reprint order form, and any other related materials to Journal Production Editor, American Journal of Dermatopathology, 215-521-8483 or 215-521-8485. Color proofs should be mailed to Journal Production Editor, American Journal of Dermatopathology, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106.
刊名字顺( Alphabetical List of Journals):
返回页首 